The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on ...

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...

Atopic dermatitis in infancy is associated with an increased risk of developing subsequent atopic march conditions such as allergy or asthma.

Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) with or without asthma and allergic rhinitis in young children.

China: A recent analysis from the National Health and Nutrition Examination Survey (NHANES) 2005–2006 revealed that ...

Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...

When 30-year-old Eve (not her real name) gave birth to her baby son, Luke (not his real name), in early 2024, she knew she ...

A total of 5 distinct atopic dermatitis phenotypes and associated characteristics were identified among children using multi-omics profiling.

The FDA approved Vtama (tapinarof) cream 1% for treating atopic dermatitis (AD) in adults and children as young as ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...